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A BST R AC T   
 
Aim: Serum uric acid is a risk factor for cardiovascular and renal diseases. The role of uric acid as a 
renal and cardiac risk factor is more prominent in subjects with diabetes mellitus and hypertension. 
In present retrospective analyze, we aimed to compare serum uric acid levels of subjects with well 
and poorly controlled type 2 diabetes mellitus (T2DM) and healthy population. 
Methods: Patients with T2DM, who admitted to outpatient clinics of our institution between April 
2017 and January 2018 were retrospectively analyzed. Diabetic subjects grouped into well or poorly 
regulated T2DM groups according to the HbA1c level (patients with an HbA1c lower than 7% were 
grouped as well regulated while others grouped as poorly regulated T2DM). Control subjects were 
healthy individuals whom asked for a routine check-up in our institution. Clinical and laboratory 
parameters of the study groups compared.  
Results: Serum uric acid levels of well-controlled T2DM, poorly controlled T2DM and control 
groups were 5.9±1, 6.7±1.8 and 4.3±1 mg/dL, respectively (p<0.001). Post Hoc analysis revealed that 
uric acid levels of well controlled diabetics were significantly lower than the uric acid levels of poorly 
controlled diabetics (p=0.04) and significantly higher than that of the control subjects (p<0.001). 
Conclusion: We suggest that elevated uric acid indicates a cellular level of damage and can be used 
as a prognostic indicator of pre-diabetes and T2DM. 
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Introduction 
Serum uric acid is a risk factor for 
cardiovascular and renal diseases [1]. The role 
of uric acid as a renal and cardiac risk factor is 
more prominent in subjects with diabetes 
mellitus and hypertension. Authors suggested 
serum uric acid levels as a predictor of worse 
outcome in stroke, atherosclerotic heart 
diseases and cerebrovascular conditions [2-4]. 
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In addition, fasting plasma glucose was 
correlated with serum uric acid levels in 
healthy population [5]. Studies in literature 
proposed serum uric acid levels as a risk factor 
for type 2 diabetes mellitus (T2DM) [6,7]. In a 
more recent study, authors suggested that 
subjects with higher serum uric acid are more 
prone to develop T2DM compare to those with 
lower uric acid levels [8].  
In present retrospective analyze, we aimed to 
compare serum uric acid levels of subjects with 
well and poorly controlled T2DM and healthy 
population. 
 
Methods 
Patients with T2DM, who admitted to 
outpatient clinics of our institution between 
April 2017 and January 2018 were 
retrospectively analyzed after obtaining 
approval of institutional directory board. 
Diabetic subjects grouped into well or poorly 
regulated T2DM groups according to the 
HbA1c level (patients with an HbA1c lower 
than 7% were grouped as well regulated while 
others grouped as poorly regulated T2DM). 
Subjects with a history or evidence of recent 
infectious disease, with hematologic or 
oncologic diseases that may effect serum uric 
acid levels, or subjects with advanced chronic 
kidney disease were excluded. Control 
subjects were healthy individuals whom asked 
for a routine check-up in our institution.  
Age, gender, body weight, waist 
circumference, height, systolic and diastolic 
blood pressure of the participants obtained 
from patient files of our clinic. A body mass 
index (BMI) simply calculated by the division 
of weight by the square of height.  
Serum uric acid, fasting plasma glucose, 
triglyceride, total, HDL and LDL cholesterol, 
HbA1c, serum creatinine levels were recorded. 
Statistical analyses were done with SPSS 
software (SPSS 11.0 for windows, IBM Co, 
Chicago, IL, USA). Homogenity of variables 
were conducted with Kolmogorov-Smirnov 
test. Variables that show normal distribution 
between study groups were analyzed with 
ANOVA test and expressed as mean ± 
Standard deviation. Variables that not show 
normal distribution were conducted with 
Kruskall- Wallis test and expressed as median 
(min-max). Categorical variables were 
analyzed with chi-square test. The p value is 
divided by the number of comparisons as the 
three groups are compared (Bonferonni 
correction).  
 
Results 
Study population was consisted of 123 
patients; 30 in well-controlled T2DM group, 
48 in poorly controlled T2DM group and 45 in 
control group. Mean age of the subjects in 
well-controlled T2DM, poorly controlled 
T2DM and control groups were 54 (43-66), 54 
(35-65) and 52 (30-59) years, respectively 
(p=0.04). 20 of 30 in well controlled T2DM 
group, 24 of 48 in poorly controlled T2DM 
group and 31 of 45 in control group were 
women. Gender distribution was not 
statistically different between study groups 
(p=0.13).  
Serum uric acid levels of well-controlled 
T2DM, poorly controlled T2DM and control 
groups were 5.9 ± 1.6, 7 ± 1.8 and 4.3 ± 1 
mg/dL, respectively. There was a significant 
difference between groups in terms of serum 
uric acid levels (p<0.001). Post Hoc analysis 
revealed that uric acid levels of well controlled 
diabetics were significantly lower than the uric 
acid levels of poorly controlled diabetics 
(p=0.04) and significantly higher than that of 
the control subjects (p<0.001). The p value is 
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divided by the number of comparisons as the 
three groups are compared (Bonferonni 
correction). 
 
Discussion 
The most important consequence of this study 
is that serum uric acid levels are higher in type 
2 diabetic patients compared to the control 
group. Another important finding is that serum 
uric acid levels in well-controlled diabetics are 
lower than those in T2DM patients with poor 
metabolic control. 
Many chronic diseases and complications such 
as T2DM may cause great economic burden all 
over the world. T2DM is a chronic metabolic 
disease characterized by relative or absolute 
insufficiency of insulin secretion and / or 
impaired carbohydrate, lipid and protein 
metabolism, which affects quality and duration 
of life due to complications and 
characterization with insulin resistance. 
Prevalence of T2DM increases and threatens 
public health via diabetes related 
complications. 
Type 2 Diabetes Mellitus is characterized with 
hyperinsulinemia, which enhances uric acid 
retention [9]. Uric acid is the final degradation 
product of purine metabolism. It has recently 
been observed that uric acid causes cell 
damage to the cell membrane with effects such 
as oxidation and inflammation [10,11]. Studies 
have found that DM, metabolic syndrome, 
hypertension and obesity are high in people 
with high uric acid levels [12-14]. If uric acid 
is excluded, other factors may help in the 
development of diabetes and the prognosis of 
diabetic patients. In this study we also 
compared healthy control patients with regular 
and non-regular diabetic patients. In our study, 
uric acid averages were 6.65mg/dL in the 
highest non-regular diabetic patients. When 
the groups are compared, the level of 
regulation is impaired and the uric acid level 
increases as shown in other studies. This 
highest detected mean hyperuricemia 
(6.5mg/dl in female, 6mg/dl in male) was close 
to the level we were referring to. Antioxidants 
can be prooxidant in certain situations [15].  
It is known that uric acid acts as an antioxidant 
in the early stages of the atherosclerotic 
process and is the strongest determinant of 
plasma antioxidant capacity [16]. However, 
when the levels of serum acid are increased to 
6 mg / dl in women and 6.5-7.0 mg / dl in men 
in the later stages of the atherosclerotic 
process, this antioxidant state paradoxically 
becomes prooxidant. This paradoxical 
condition seems to depend on several 
environmental factors such as the stage of the 
disease process, tissue and substrate 
localization, acidity, oxidant environment, 
other local antioxidant decrease, oxidant and 
enzyme release and medium availability [17]. 
In another study on type 1 DM, oxidative stress 
was also shown to be increased by the effect of 
nitric oxide in cases where the uric acid level 
fell below 3 mg/dL [18]. In a recent study, 
authors found that serum uric acid levels of 
well controlled type 2 diabetic subjects were 
significantly lower than the uric acid of poorly 
controlled T2DM patients [19]. Similarly, we 
also report that poorly controlled diabetics 
have significantly higher uric acid levels 
compared to well controlled diabetic subjects. 
Relatively small population is a limitation of 
present study. Another limitation is the 
retrospective design of our work.  
In conclusion, according to the results of the 
studies, uric acid is an antioxidant substance 
and oxidative stress and diabetic complications 
increase when it falls below 3 mg / dl. 
However, it affects as prooxidant in cases 
exceeding 6 mg / dL. Therefore, we suggest 
that elevated uric acid indicates a cellular level 
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of damage and can be used as a prognostic 
indicator of pre-diabetes and T2DM. 
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